| Literature DB >> 27859662 |
Zichao Luo1, Qinjie Wu2, Chengbiao Yang3, Huaimin Wang3, Tao He2, Youzhi Wang3, Zhongyan Wang3, Hao Chen4, Xingyi Li4, Changyang Gong2, Zhimou Yang3.
Abstract
A novel vaccine adjuvant based on a supramolecular hydrogel of a D-tetra-peptide is reported. Antigens can be easily incorporated into the hydrogel by a vortex or by gently shaking before injection. The vaccines can stimulate strong CD8+ T-cell responses, which significantly inhibits tumor growth. This novel adjuvant is expected to enable a wide range of sub-unit vaccines and help the production of antibodies.Entities:
Keywords: adjuvants; cancer therapy; hydrogels; peptides; vaccines
Mesh:
Substances:
Year: 2016 PMID: 27859662 DOI: 10.1002/adma.201601776
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849